{"url_path":"/sec/mtnb/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1582554/0001493152-26-022010-index.html","accession_number":"0001493152-26-022010","cik":"0001582554","ticker":"MTNB","issuer_name":"Matinas BioPharma Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1582554/0001493152-26-022010-index.html","primary_entity_key":"0001582554","primary_entity_name":"Matinas BioPharma Holdings, Inc."},"word_count":481,"has_tables":true,"body_markdown":"**Item\n6. EXHIBITS.**\n\n \n\nSee\nthe Exhibit Index following the signature page to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this\nreport, which Exhibit Index is incorporated herein by reference.\n\n \n\n22\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \n**MATINAS\nBIOPHARMA HOLDINGS, INC.**\n\n \n \n\n \nBY:\n\n \n \n\n \n*/s/\nJerome D. Jabbour*\n\nDated:\nMay 8, 2026\nJerome\nD. Jabbour\n\n \nChairman,\nChief Executive Officer, President & Interim Chief Financial Officer\n\n \n(Principal\nExecutive Officer and Principal Financial and Accounting Officer)\n\n \n\n23\n\n \n\n \n\nEXHIBIT\nINDEX\n\n \n\n3.1\n \n[Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 filed with the SEC on February 7, 2014).](https://www.sec.gov/Archives/edgar/data/1582554/000114420414006883/v367181_ex3-1.htm)\n\n3.2\n \n[Bylaws (incorporated by reference to Exhibit 3.2 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 filed with the SEC on February 7, 2014).](https://www.sec.gov/Archives/edgar/data/1582554/000114420414006883/v367181_ex3-2.htm)\n\n3.3\n \n[Certificate of Amendment of Certificate of Incorporation, dated October 29, 2015 . (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 5, 2015).](https://www.sec.gov/Archives/edgar/data/1582554/000114420415063074/v423741_ex3-1.htm)\n\n3.4\n \n[Certificate of Amendment of Certificate of Incorporation, dated August 30, 2024 (incorporated by reference to Exhibit 3.1 the Company’s Current Report on Form 8-K filed with the SEC on September 3, 2024).](https://www.sec.gov/Archives/edgar/data/1582554/000149315224034729/ex3-1.htm)\n\n3.5\n \n[Form of Certificate of Designation of Series C Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2025).](https://www.sec.gov/Archives/edgar/data/1582554/000149315225006481/ex3-1.htm)\n\n3.6\n \n[Amendment No. 1 to the Bylaws (incorporated by reference to Exhibit 3.1 the Company’s Current Report on Form 8-K filed with the SEC on May 2, 2025).](https://www.sec.gov/Archives/edgar/data/1582554/000164117225008417/ex3-1.htm)\n\n3.7\n \n[Certificate of Amendment of Certificate of Incorporation, dated August 6, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 6, 2025).](https://www.sec.gov/Archives/edgar/data/1582554/000164117225022445/ex10-1.htm)\n\n*31.1\n \n[Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*](ex31-1.htm)\n\n**32.1\n \n[Section 1350 Certification](ex32-1.htm)\n\n \n \n \n\n*101.1\n \nInline\nXBRL Instance Document.\n\n*101.2\n \nInline\nXBRL Taxonomy Extension Schema Document.\n\n*101.3\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n*101.4\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n\n*101.5\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n\n*101.6\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*\nFiled herewith.\n\n \n\n**The\ninformation in this exhibit is furnished and deemed not filed with the SEC for purposes of section 18 of the Exchange Act of 1934, as\namended, and is not to be incorporated by reference into any filing of Matinas BioPharma Holdings, Inc. under the Securities Act or the\nExchange Act of whether made before or after the date hereof, regardless of any general incorporation language in such filing.\n\n \n\n24\n\n** **"}